抗VEGF联合激光治疗重度非增殖期糖尿病视网膜病变对黄斑区血流密度的影响
1资料和方法,2结果,3讨论
【摘要】目的:分析抗VEGF联合激光治疗重度非增殖期糖尿病视网膜病变的临床疗效。方法:选取2023年1月—2023年11月间我院收治的20例重度非增殖期糖尿病视网膜病变患者作为研究对象,随机将其分为对照组和观察组,各10例,分别采取单纯激光治疗和抗VEGF联合激光治疗,对比两组患者治疗效果。结果:治疗后,观察组患者治疗总有效率、视力、眼压及黄斑视网膜厚度均显著优于对照组(P<0.05)。治疗后,两组患者的SCP血流密度均优于治疗前,差异有统计学意义(P<0.05);治疗后,两组患者的SCP血流密度差异不大(P>0.05)。对照组患者治疗前后的DCP血流密度差异不大(P>0.05);治疗后,观察组患者的DCP血流密度显著优于对照组(P<0.05)。结论:抗VEGF联合激光治疗重度非增殖期糖尿病视网膜病变的效果理想,可以显著改善患者黄斑区血流密度,提升患者视力水平,建议临床应用。【关键词】抗VEGF联合激光治疗;重度非增殖期糖尿病视网膜病变;黄斑区;血流密度;影响
基金项目:昆明理工大学医学联合专项《抗VEGF 治疗对非增殖期糖尿病视网膜病变的疗效研究》(项目编号:KUST一KH2022036Y)
Effect of anti-VEGF combined with laser on blood flow density in macular region in the treatment of severe non-proliferative diabetic retinopathy
HE Dongqiong, HAN Kunping
The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650000, China
【Abstract】Objective:To analyze the clinical efficacy of anti-VEGF combined with laser in the treatment of severe non-proliferative diabetic retinopathy.Methods:Twenty patients with severe non-proliferative diabetic retinopathy admitted to our hospital from January 2023 to November 2023 were selected as the research objects ......
您现在查看是摘要页,全文长 8780 字符。